Soroush Nematollahi: Antiphospholipid Syndrome Manifesting as Myocardial Infarction
Soroush Nematollahi, Postdoctoral Research Fellow at Tehran Heart Cente, shared a post on LinkedIn:
“Our most recent case report has just been published:
“Antiphospholipid Syndrome Manifesting as Myocardial Infarction: A Case Report and Review of the Literature.”
This work highlights how APS can present as acute MI, complicating PCI with migratory thrombi, and underscores the importance of thrombophilia screening in young patients. We also review the literature to emphasize tailored anticoagulation strategies and long-term management.
Grateful to my co-authors and colleagues for their collaboration.”
Title: Antiphospholipid Syndrome Manifesting as Myocardial Infarction: A Case Report and Review of the Literature.
Authors: Shayan Shahi, Soroush Nematollahi, Amirali Mohammadi, Hassan Aghajani
Rea the full case report.
Stay informed with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids